108 results on '"Stewart, Paul"'
Search Results
2. Clinical practice and nomenclature of Pituitary neoplasms: Common sense must prevail
3. Tissue Glucocorticoid Metabolism in Adrenal Insufficiency: A Prospective Study of Dual-release Hydrocortisone Therapy
4. Mendelian Randomization Studies in Endocrinology: Raising the Quality Bar for Submissions and Publications in The Journal of Clinical Endocrinology & Metabolism
5. The Effect of Endogenous Cushing Syndrome on All-cause and Cause-specific Mortality
6. Effect of AZD4017, a Selective 11β-HSD1 Inhibitor, on Bone Turnover Markers in Postmenopausal Osteopenia
7. Environmental Pollution, Climate Change, and a Critical Role for the Endocrinologist
8. Gender-Specific Differences in Skeletal Muscle 11β-HSD1 Expression Across Healthy Aging
9. Case for the Wider Adoption of Mass Spectrometry-Based Adrenal Steroid Testing, and Beyond
10. Clinical Practice and Nomenclature of Pituitary Neoplasms: Common Sense Must Prevail
11. Diminished 11β-Hydroxysteroid Dehydrogenase Type 2 Activity Is Associated With Decreased Weight and Weight Gain Across the First Year of Life
12. Hyperandrogenemia Predicts Metabolic Phenotype in Polycystic Ovary Syndrome: The Utility of Serum Androstenedione
13. A Paradigm Shift in the Monitoring of Patients With Acromegaly: Last Available Growth Hormone May Overestimate Risk
14. El aldosteronismo primario
15. Primary Aldosteronism
16. Improved Urinary Cortisol Metabolome in Addison Disease: A Prospective Trial of Dual-Release Hydrocortisone
17. 11βHSD1 Inhibition with AZD4017 Improves Lipid Profiles and Lean Muscle Mass in Idiopathic Intracranial Hypertension
18. Glucocorticoids Fail to Cause Insulin Resistance in Human Subcutaneous Adipose Tissue In Vivo
19. Mitotane Therapy in Adrenocortical Cancer Induces CYP3A4 and Inhibits 5α-Reductase, Explaining the Need for Personalized Glucocorticoid and Androgen Replacement
20. Outcome of Cushingʼs Disease following Transsphenoidal Surgery in a Single Center over 20 Years
21. Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors
22. Our Response to COVID-19 as Endocrinologists and Diabetologists
23. Cerebrospinal Fluid Corticosteroid Levels and Cortisol Metabolism in Patients with Idiopathic Intracranial Hypertension: A Link between 11β-HSD1 and Intracranial Pressure Regulation?
24. Is Subclinical Cushingʼs Syndrome an Entity or a Statistical Fallout from Diagnostic Testing? Consensus Surrounding the Diagnosis Is Required before Optimal Treatment Can Be Defined
25. The Role of 11ß-Hydroxysteroid Dehydrogenase 1 in Adipogenesis in Thyroid-Associated Ophthalmopathy
26. 11β-Hydroxysteroid Dehydrogenase Type 1 and Its Role in the Hypothalamus-Pituitary-Adrenal Axis, Metabolic Syndrome, and Inflammation
27. Increased 5α-Reductase Activity and Adrenocortical Drive in Women with Polycystic Ovary Syndrome
28. Steroid Biomarkers and Genetic Studies Reveal Inactivating Mutations in Hexose-6-Phosphate Dehydrogenase in Patients with Cortisone Reductase Deficiency
29. The Diagnosis of Cushingʼs Syndrome: An Endocrine Society Clinical Practice Guideline
30. Modulation of 11β-Hydroxysteroid Dehydrogenase (11βHSD) Activity Biomarkers and Pharmacokinetics of PF-00915275, a Selective 11βHSD1 Inhibitor
31. Glucocorticoid Modulation of Insulin Signaling in Human Subcutaneous Adipose Tissue
32. Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Activity in Vivo Limits Glucocorticoid Exposure to Human Adipose Tissue and Decreases Lipolysis
33. Dissociation of Serum Dehydroepiandrosterone and Dehydroepiandrosterone Sulfate in Septic Shock
34. The Long-Term Predictive Accuracy of the Short Synacthen (Corticotropin) Stimulation Test for Assessment of the Hypothalamic-Pituitary-Adrenal Axis
35. Sex Steroid Metabolism in Human Peripheral Blood Mononuclear Cells Changes with Aging
36. Expression Profiles for Steroidogenic Enzymes in Adrenocortical Disease
37. Letter re: Monitoring the Response to Treatment in Acromegaly
38. No Evidence for Hepatic Conversion of Dehydroepiandrosterone (DHEA) Sulfate to DHEA: In Vivo and in Vitro Studies
39. Editorial: Adrenal Replacement Therapy: Time for an Inward Look to the Medulla?
40. Weight Loss Increases 11β-Hydroxysteroid Dehydrogenase Type 1 Expression in Human Adipose Tissue
41. 11β-Hydroxysteroid Dehydrogenase Type 1 Activity Predicts the Effects of Glucocorticoids on Bone
42. Hypertension and the Cortisol-Cortisone Shuttle
43. Low-Dose Growth Hormone Inhibits 11β-Hydroxysteroid Dehydrogenase Type 1 but Has No Effect upon Fat Mass in Patients with Simple Obesity
44. Long-Term Safety and Efficacy of Depot Long-Acting Somatostatin Analogs for the Treatment of Acromegaly
45. Glucocorticoid Regulation of P450 Aromatase Activity in Human Adipose Tissue: Gender and Site Differences
46. A Switch in Dehydrogenase to Reductase Activity of 11β-Hydroxysteroid Dehydrogenase Type 1 upon Differentiation of Human Omental Adipose Stromal Cells
47. Absence of Cushingoid Phenotype in a Patient with Cushing’s Disease due to Defective Cortisone to Cortisol Conversion
48. Expression of 11β-Hydroxysteroid Dehydrogenase Isoenzymes in the Human Pituitary: Induction of the Type 2 Enzyme in Corticotropinomas and Other Pituitary Tumors
49. Extrarenal Expression of 25-Hydroxyvitamin D3-1α-Hydroxylase*
50. Loss of Estrogen Inactivation in Colonic Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.